by Ari Navetta September 10, 2026 Entrepreneurship , Biomedical Science , School of Engineering Share Everyone has dreamt of a pain-free alternative to needles, while anticipating your annual flu shot or grimacing through self-injections. Luckily, this future may be close at hand, due to the work of a Boston-based startup founded by Tufts alumni. Anodyne Nanotech draws on Tufts research to create patches of miniscule microneedles that are applied to the skin, offering a new form of drug delivery
EntrepreneurshipBiomedical ScienceMedical Research#Tufts University#Entrepreneurship#Biomedical Science#Tufts Now#medical research#clinical research
Medical ResearchLife SciencesEnvironment & Climate#Kennesaw State University#research#News Releases#medical research#clinical research#genomics#biology#climate
by Grace van Deelen September 10, 2026 Health , Infectious Disease , School of Medicine Share Cases of measles, a highly contagious and deadly disease, are surging in parts of the U.S., worrying doctors and public health experts. In 2026, so far, 3 ,134 cases have been reported across 47 states, according to the Centers for Disease Control and Prevention (CDC). About 8% of those people required hospitalization. In 2025, the CDC reported 2,289 cases of measles, compared to only 58 in 2023. Some c
HealthInfectious DiseaseMedical Research#Tufts University#Health#infectious disease#Tufts Now#medical research#clinical research
Living human cells will launch aboard a European research rocket next month as South Australian researchers use space to investigate cancer in a radically different environment.
In her new leadership role, Chiappinelli will build cancer research programs while continuing her work on how ancient viral DNA can trigger anti-tumor immune responses.
Medical ResearchLife Sciences#George Washington University#Research News#SMHS#medical research#clinical research#genomics#biology
In her new leadership role, Chiappinelli will build cancer research programs while continuing her work on how ancient viral DNA can trigger anti-tumor immune responses.
Medical ResearchLife Sciences#George Washington University#Research News#SMHS#medical research#clinical research#genomics#biology
A University of Minnesota-led multi-institutional research team has discovered a highly potent small molecule that blocks Ebola virus entry by stabilizing the virus's entry protein and provides strong protection when given orally in a preclinical model.
Medical ResearchLife SciencesResearch#University of Minnesota Medical School#UMN Medical School#research#medical research#clinical research#genomics#biology
by Monica Jimenez September 7, 2026 Arts & Humanities , Science & Technology , Graduate School of Arts and Sciences , School of Arts and Sciences Share A real lesson from Star Trek “One of the reasons I had the class watch Voyager’s ‘Living Witness’ is that I think it is one of the best Star Trek episodes about the way history actually works. The Doctor wakes up centuries later and finds a museum presenting Voyager and its crew as these brutal, almost monstrous figures. But what is really intere
The human body is a marvel of remake and renewal. We regularly replace some of our estimated 37 trillion cells – about 300 billion or 1 percent of our cells each day - with healthy substitutes. We remove damaged or aging, senescent cells and cellular debris from our organs and tissues every second of the day. How important is it that cellular waste be properly removed?
Medical ResearchLife SciencesEnvironment & Climate#University of Minnesota Medical School#UMN Medical School#Immunology#medical research#clinical research#genomics#biology#climate
